LONDON, Dec. 15, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research on the neuroscience antibodies & assays market, the increasing incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward. Neurological illnesses are disorders affecting the nervous system and examples of neurological disorders include epilepsy, alzheimer's disease, dementia and so on. The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases. Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system. Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses.
For instance, According to World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer's Association a US based Non-profit association, 6.5 million people in the US have Alzheimer's disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.
Request for a sample of the global neuroscience antibodies & assays market report
The global neuroscience antibodies & assays market size is expected to grow from $3.22 billion in 2021 to $3.58 billion in 2022 at a compound annual growth rate (CAGR) of 11.21%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The neuroscience antibodies & assays market is expected to reach $5.43 billion in 2026 at a compound annual growth rate (CAGR) of 10.97%.
Technological advancements are a key trend gaining popularity in the neuroscience antibodies and assays market. Major companies operating in the market are introducing new technologies such as Cisbio HTRF® that works on TR-FRET technology to sustain their position in the market. For instance, in October 2020, PerkinElmer Inc, a US-based diagnostics, life sciences, and environmental research company, launched ‘PerkinElmer Cisbio HTRF® Phospho-Ubiquitin (Ser65) Cellular Kit’. The new kit has applications in various disease areas such as Alzheimer’s and Parkinson’s disease. The novel assay’s can be applied to increase study specificity for the Phospho-Ubiquitin (Ser65) intersection point. With the help of TR-FRET technology helps to identify crucial mitophagy dysfunction and breakdowns in the intricate network between neurons and glial cells that can result in neurodegenerative disease.
Major players in the neuroscience antibodies & assays market are Abcam PLC, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Merck KgaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens Healthineers, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Enzo Life Sciences AG.
North America was the largest region in the neuroscience antibodies & assays market in 2021. The regions covered in neuroscience antibodies & assays market research are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The global neuroscience antibodies and assays market analysis is segmented by product into consumables, instruments; by technology into molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, others technologies; by application into in vitro diagnostics, research, drug discovery; by end user into hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies.
Neuroscience Antibodies & Assays Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provide neuroscience antibodies & assays market forecast size and growth, neuroscience antibodies & assays market segments, neuroscience antibodies & assays market trends, drivers and restraints, leading competitors’ revenues, profiles and market shares in its competitive landscape section for over 3,000 industry reports, covering more than 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Not the market you are looking for? Check out some similar market intelligence reports:
Neurology Devices Global Market Report 2022 – By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices), By End User (Hospitals And Clinics, Diagnostic Laboratories), By Type Of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2022-2026
Neurophysiology Devices And Equipment Global Market Report 2022 – By Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked Potential (EP)), By End Users (Hospitals, Ambulatory Surgical Centers), By Modality (Standalone, Portable) – Market Size, Trends, And Global Forecast 2022-2026
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
